FDA approves Praluent injections to help lower cholesterol
The U.S. Food and Drug Administration late last week approved Praluent injections, the first cholesterol-lowering treatment cleared for use in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors. Read More »